Skip to content

13F-HR filed by BRIDGER MANAGEMENT, LLC

BRIDGER MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 43 holding rows worth $443,623,000.

Accession
0001166309-22-000006
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 43 entries on the cover page, a total value of $443,623,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $443,623,000 with VALUE read as thousands by filing date, 13F file number 028-10079. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHARTER COMMUNICATIONS INC N16119P108COM68,159$31,935,000thousands by filing date
GODADDY INC CL A380237107Stock445,953$31,020,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock318,300$26,931,000thousands by filing date
Morgan Stanley617446448COM342,214$26,029,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR376,600$24,882,000thousands by filing date
CLARIVATE PLCG21810109ORD SHS1,641,319$22,749,000thousands by filing date
ALCON AG ORD SHSH01301128Stock313,115$21,884,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM73,072$20,591,000thousands by filing date
Uber Technologies90353T100COM993,309$20,323,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM207,800$17,220,000thousands by filing date
HUMANA INC COM444859102Stock35,000$16,382,000thousands by filing date
CAESARS ENTERTAINMENT INC NE12769G100COM411,753$15,770,000thousands by filing date
VERISIGN INC COM92343E102Stock93,753$15,688,000thousands by filing date
SKINHEALTH SYSTEMS INC88331L108COM CL A1,094,710$14,078,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock119,779$12,940,000thousands by filing date
POST HOLDINGS PARTNERING COR737465203UNIT 99/99/99991,250,000$12,213,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,500,000$11,280,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK956,014$11,023,000thousands by filing date
AVANTI ACQUISITION CORP UNITG0682V117Stock1,000,000$10,000,000thousands by filing date
AIRSCULPT TECHNOLOGIES INC009496100COMMON STOCK1,634,941$9,695,000thousands by filing date
WILLIAMS ROWLAND ACQUISITION96951B102COM950,000$9,500,000thousands by filing date
INSULET CORP COM45784P101Stock41,000$8,936,000thousands by filing date
POST HLDGS INC737446104COM100,298$8,260,000thousands by filing date
FLAME ACQUISITION CORP33850F108COM CL A500,000$4,895,000thousands by filing date
RXSIGHT INC78349D107COM331,432$4,667,000thousands by filing date
BELLRING BRANDS INC COMMON STOCK07831C103Stock187,122$4,657,000thousands by filing date
DOCEBO INC COM25609L105Stock150,300$4,309,000thousands by filing date
R1 RCM INC77634L105COM186,000$3,899,000thousands by filing date
LIVANOVA PLCG5509L101SHS55,890$3,491,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock77,400$2,355,000thousands by filing date
QUANTERIX CORP74766Q101COMMON STOCK144,684$2,342,000thousands by filing date
ADVISORSHARES TR00768Y453PURE US CANNABIS214,100$2,216,000thousands by filing date
Surrozen, Inc.86889P109COM700,001$2,100,000thousands by filing date
ABCAM PLC000380204ADR USD142,350$2,058,000thousands by filing date
DERMTECH INC24984K105COM350,800$1,943,000thousands by filing date
PRIVIA HEALTH GROUP INC74276R102COM44,400$1,293,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK278,000$1,251,000thousands by filing date
NAUTILUS BIOTECHNOLOGY INC63909J108COM289,000$777,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM66,300$767,000thousands by filing date
NEXIMMUNE INC65344D109COM400,000$644,000thousands by filing date
BIO-TECHNE CORP09073M104COM1,444$501,000thousands by filing date
SURROZEN INC86889P117*W EXP 08/01/203466,666$89,000thousands by filing date
WILLIAMS ROWLAND ACQUISITION96951B110*W EXP 12/11/202475,000$40,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001166309-22-000006this filing2022-08-15acceptance time not in the bulk data set